Shanghai RAAS Blood Products Co Ltd Class A - Asset Resilience Ratio

Latest as of June 2024: 4.52%

Shanghai RAAS Blood Products Co Ltd Class A (002252) has an Asset Resilience Ratio of 4.52% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Shanghai RAAS Blood Products Co Ltd Clas balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.46 Billion
≈ $214.13 Million USD Cash + Short-term Investments

Total Assets

CN¥32.37 Billion
≈ $4.74 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2023)

This chart shows how Shanghai RAAS Blood Products Co Ltd Class A's Asset Resilience Ratio has changed over time. See Shanghai RAAS Blood Products Co Ltd Clas book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shanghai RAAS Blood Products Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Shanghai RAAS Blood Products Co Ltd Clas.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.46 Billion 4.52%
Total Liquid Assets CN¥1.46 Billion 4.52%

Asset Resilience Insights

  • Limited Liquidity: Shanghai RAAS Blood Products Co Ltd Class A maintains only 4.52% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai RAAS Blood Products Co Ltd Class A Industry Peers by Asset Resilience Ratio

Compare Shanghai RAAS Blood Products Co Ltd Class A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Merus BV
NASDAQ:MRUS
Biotechnology 29.69%
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
Biotechnology 30.29%
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
Biotechnology 8.08%
Beijing Hotgen Biotech Co Ltd
SHG:688068
Biotechnology 20.87%
Savara Inc
NASDAQ:SVRA
Biotechnology 76.71%
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871
Biotechnology 9.59%
Wecome Pharmaceutical Co Ltd
SHE:300878
Biotechnology 0.67%
Shanghai Shen Lian Biomedical Corp
SHG:688098
Biotechnology 3.87%

Annual Asset Resilience Ratio for Shanghai RAAS Blood Products Co Ltd Class A (2014–2023)

The table below shows the annual Asset Resilience Ratio data for Shanghai RAAS Blood Products Co Ltd Class A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.62% CN¥197.41 Million
≈ $28.89 Million
CN¥31.93 Billion
≈ $4.67 Billion
-0.16pp
2022-12-31 0.78% CN¥237.77 Million
≈ $34.79 Million
CN¥30.46 Billion
≈ $4.46 Billion
-0.02pp
2021-12-31 0.81% CN¥219.38 Million
≈ $32.10 Million
CN¥27.24 Billion
≈ $3.99 Billion
-0.22pp
2020-12-31 1.03% CN¥262.14 Million
≈ $38.36 Million
CN¥25.49 Billion
≈ $3.73 Billion
-1.46pp
2019-12-31 2.49% CN¥295.40 Million
≈ $43.23 Million
CN¥11.85 Billion
≈ $1.73 Billion
-0.38pp
2018-12-31 2.87% CN¥327.05 Million
≈ $47.86 Million
CN¥11.39 Billion
≈ $1.67 Billion
-18.82pp
2017-12-31 21.70% CN¥3.14 Billion
≈ $458.95 Million
CN¥14.46 Billion
≈ $2.12 Billion
+5.39pp
2016-12-31 16.31% CN¥2.16 Billion
≈ $315.65 Million
CN¥13.23 Billion
≈ $1.94 Billion
+2.35pp
2015-12-31 13.96% CN¥1.61 Billion
≈ $236.05 Million
CN¥11.56 Billion
≈ $1.69 Billion
+13.94pp
2014-12-31 0.02% CN¥2.00 Million
≈ $292.66K
CN¥9.38 Billion
≈ $1.37 Billion
--
pp = percentage points

About Shanghai RAAS Blood Products Co Ltd Class A

SHE:002252 China Biotechnology
Market Cap
$5.52 Billion
CN¥37.70 Billion CNY
Market Cap Rank
#3381 Global
#518 in China
Share Price
CN¥5.68
Change (1 day)
+2.16%
52-Week Range
CN¥5.47 - CN¥7.18
All Time High
CN¥24.72
About

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human serum albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human thrombin and human fibrin adhesive, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. The… Read more